Jan Wald

Jan Wald has had a diverse range of work experience in the healthcare industry. Jan is currently a Senior Consultant at Alira Health, where they began working in May 2023. Prior to that, they held the position of Vice President Clinical and Medical Programs at AltaThera Pharmaceuticals starting in January 2021. In the same year, they also served as an Advisor at Kaminari Medical.

From 2018 to 2023, Jan worked at Silverwood Partners as a Managing Director Advisor. In 2018, they also served as a Managing Director at MedWorld Advisors. Before that, they were the VP Corporate Development at Ornim Medical from 2017 to 2018.

Jan gained expertise in the healthcare investment sector during their time as Managing Director, Healthcare, at The Benchmark Company, LLC from 2013 to 2017. Jan'scareer also includes a role as an Advisor at Cardialysis from 2009 to 2013, where they focused on electrophysiology and stem cells clinical trial markets.

Earlier in their career, Jan worked as a Senior Medical Technology Analyst at Morgan Keegan in 2011 and held the position of Managing Director at The Stanford Group from 2007 to 2009.

Jan Wald has a PhD in Philosophy from Brandeis University. They also have a Bachelor of Arts (B.A.) in Philosophy from Northeastern University. Furthermore, Jan Wald completed a Post Doctoral program at the University of Minnesota. They also obtained an MBA in Finance from the University of St. Thomas - Opus College of Business.